Harvard Bioscience, Inc.HBIONASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-9.3%
5Y CAGR-3.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-9.3%/yr
vs +2.0%/yr prior
5Y CAGR
-3.2%/yr
Recent deceleration
Acceleration
-11.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.96M | -15.4% |
| 2024 | $43.70M | -6.8% |
| 2023 | $46.89M | -5.3% |
| 2022 | $49.53M | +1.2% |
| 2021 | $48.95M | +12.7% |
| 2020 | $43.42M | -5.6% |
| 2019 | $46.02M | +0.4% |
| 2018 | $45.83M | +15.7% |
| 2017 | $39.61M | -4.4% |
| 2016 | $41.44M | - |